Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Evidence-Based Treatment for Ischemic Heart Disease Needed
March 26, 2001
- Freund Creates New Company to Contract Manufacture Investigational New Drugs in US
March 26, 2001
- Company Reform Is Half-way Point to Top of Mountain: Takeda
March 26, 2001
- Fibrate Drugs Effective against Hypertriglyceridemia
March 26, 2001
- Clinical Trials Must Be Promoted from the Patients' Viewpoint: Prof. Nakano
March 26, 2001
- Seiwa Sangyo Introduces New System to Cut Costs
March 26, 2001
- WORLD NEWS IN BRIEF
March 26, 2001
- Introduction of CRC Certification System Being Considered
March 26, 2001
- Chuikyo Subcommittee to Form Consensus on Drug Prices by Autumn
March 26, 2001
- Mucosal Influenza Vaccine More Effective than Conventional Vaccines
March 26, 2001
- Mochida to Restructure Its Production System
March 26, 2001
- Chuikyo Subcommittee Starts Discussions for Next Revision of Medical Fees
March 26, 2001
- Draft Guidelines on Genetic Testing Compiled by Eight Societies
March 26, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
March 26, 2001
- 850 Questions Received Regarding Evidence for Off-label Use of Drugs
March 26, 2001
- Gene Therapy for Buerger's Disease to Be Approved Shortly
March 26, 2001
- Applications Aimed at Preventing Accidents to Be Approved Quickly
March 26, 2001
- DIAGNOSTIC NEWS IN BRIEF
March 26, 2001
- LDP Convention Calls For Radical Reform in 2002
March 26, 2001
- MEDICAL DEVICE NEWS IN BRIEF
March 26, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…